We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Blood Stem Cells Induce Tolerance for Transplanted Organs

By HospiMedica staff writers
Posted on 12 Feb 2002
Peripheral blood stem cell transplantation, used for patients with certain cancers, now shows promise as a way to induce drug-free tolerance of a transplanted organ, according to researchers at the University of Pittsburgh (PA, USA).

Three days after receiving a kidney donated by her brother, a transplant recipient at the university's Thomas E. More...
Starzl Transplantation Institute received an infusion of her brother's immune system cells taken from blood he had donated earlier. The procedure took less than 20 minutes and both donor and recipient were discharged five days later.
The recipient's transplanted kidney is functioning well, with no complications from the stem cell infusion. The doctors say it will be several months before they can determine whether she can be weaned of immunosuppressive drugs.

Surgeons at the university have been evaluating the long-term benefits of giving transplant recipients unmodified donor bone marrow infusions as a means to enhance chimerism. As with these transplants, the aim of the new treatment is to boost the level of chimerism, in the hope that tolerance is more likely to follow and the patient can be successfully weaned off immunosuppressive drugs.

"Unlike liver transplant patients, very few kidney recipients have been able to be safely weaned off immunosuppression,” noted Ron Shapiro, M.D., professor of surgery at the Starzl Transplantation Institute. "We think this is because the kidney contains fewer of the types of cells that are immunoprotective.”




Related Links:
Univ. of Pennsylvania

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.